China’s Duality Biotherapeutics Seeks IPO to Accelerate ADC Development
China's clinical-stage biotech company, Duality Biotherapeutics, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. ...
AsiaTechDaily – Asia's Leading Tech and Startup Media Platform
China's clinical-stage biotech company, Duality Biotherapeutics, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. ...
South Korea's Digital Health Innovation Advances Toward Global Expansion HAII Corporation, a South Korean digital health company, has obtained approval ...
Pangyo Techno Valley, Korea's most extensive R&D nexus, is rapidly ascending as a pivotal center for biotechnology. Nestled within this ...